当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:177.64亿  总市值:177.71亿
流通股本:11.58亿   总股本:11.58亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,798,660,551.633,905,925,550.522,047,554,062.499,716,872,993.65
  收到的税费返还304,318,738.35139,558,274.03129,949,532.27426,914,185.73
  收到其他与经营活动有关的现金190,903,061.3382,923,248.6750,168,005.63267,682,607.59
  经营活动现金流入小计6,293,882,351.314,128,407,073.222,227,671,600.3910,411,469,786.97
  购买商品、接受劳务支付的现金3,824,738,181.962,507,807,853.951,549,400,995.386,954,988,912.15
  支付给职工以及为职工支付的现金710,162,856.09525,337,963.25334,857,072.87994,709,846.91
  支付的各项税费402,637,442.7303,868,594.79188,779,313.84453,982,711.64
  支付其他与经营活动有关的现金582,319,763.89384,212,100.91169,627,687.46799,034,633.26
  经营活动现金流出小计5,519,858,244.643,721,226,512.92,242,665,069.559,202,716,103.96
  经营活动产生的现金流量净额774,024,106.67407,180,560.32-14,993,469.161,208,753,683.01
二、投资活动产生的现金流量:
  收回投资收到的现金943,187,974.61502,027,895.5229,954,791.43860,292,262.61
  取得投资收益收到的现金10,468,676.8910,468,676.8910,468,676.8919,600,000
  处置固定资产、无形资产和其他长期资产收回的现金净额2,354,172.451,437,975.94814,711.048,513,207.31
  处置子公司及其他营业单位收到的现金净额30,054,923.3330,054,923.3330,054,923.337,600,000
  收到的其他与投资活动有关的现金265,160.64--2,620,599
  投资活动现金流入小计986,330,907.92543,989,471.66271,293,102.69898,626,068.92
  购建固定资产、无形资产和其他长期资产支付的现金219,483,024.29165,748,763.93125,815,890.84460,745,527.76
  投资支付的现金1,004,745,500506,847,900236,847,900825,532,427.56
  支付其他与投资活动有关的现金427,910.98136,560-10,359,846
  投资活动现金流出小计1,224,656,435.27672,733,223.93362,663,790.841,296,637,801.32
  投资活动产生的现金流量净额-238,325,527.35-128,743,752.27-91,370,688.15-398,011,732.4
三、筹资活动产生的现金流量:
  吸收投资收到的现金---505,050
  其中:子公司吸收少数股东投资收到的现金---505,050
  取得借款收到的现金1,620,900,0001,062,900,000296,900,0001,388,380,014.79
  筹资活动现金流入小计1,620,900,0001,062,900,000296,900,0001,388,885,064.79
  偿还债务支付的现金1,164,000,000673,000,000320,100,0001,405,844,000
  分配股利、利润或偿付利息支付的现金836,012,075.14428,077,335.276,765,243.37401,629,843.49
  支付其他与筹资活动有关的现金190,673,547.93182,481,791.381,431,062.9163,562,602.42
  筹资活动现金流出小计2,190,685,623.071,283,559,126.65328,296,306.271,971,036,445.91
  筹资活动产生的现金流量净额-569,785,623.07-220,659,126.65-31,396,306.27-582,151,381.12
四、汇率变动对现金及现金等价物的影响3,355,523.377,432,261.763,246,242.9338,368,228.83
五、现金及现金等价物净增加额-30,731,520.3865,209,943.16-134,514,220.65266,958,798.32
  加:期初现金及现金等价物余额2,729,444,560.062,729,444,560.062,729,444,560.062,462,485,761.74
  期末现金及现金等价物余额2,698,713,039.682,794,654,503.222,594,930,339.412,729,444,560.06
补充资料:
  净利润-563,071,412.09-1,030,846,722.3
  资产减值准备-23,620,350.55-69,303,010.56
  固定资产和投资性房地产折旧-316,106,648.1-566,863,534.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-316,106,648.1-566,863,534.09
  无形资产摊销-5,769,821.05-11,154,526.62
  长期待摊费用摊销-3,554,724.68-6,253,865.47
  处置固定资产、无形资产和其他长期资产的损失--1,159,599.1--279,470.84
  固定资产报废损失-1,970,461.3-8,368,983.61
  公允价值变动损失-42,550.68--7,965,391.23
  财务费用--21,116,281.94--5,344,052.9
  投资损失--35,840,695.16-1,753,932.65
  递延所得税-2,339,587.79-1,009,201.3
  其中:递延所得税资产减少-10,607,927.42-19,740,749.8
    递延所得税负债增加--8,268,339.63--18,731,548.5
  存货的减少-166,191,966.2-152,988,779.49
  经营性应收项目的减少--78,948,649.83--251,453,661.58
  经营性应付项目的增加--541,765,743.78--375,303,021.38
  其他---556,724.85
  现金的期末余额-2,794,654,503.22-2,729,444,560.06
  减:现金的期初余额-2,729,444,560.06-2,462,485,761.74
  现金及现金等价物的净增加额-65,209,943.16-266,958,798.32
公告日期2025-10-222025-08-202025-04-182025-03-11
审计意见(境内)标准无保留意见
TOP↑